Related Articles Integration of Palliative Care Into Standard Oncology Care: ASCO Clinical Practice Guideline Update Summary. J Oncol Pract. 2017 02;13(2):119-121 Authors: Ferrell BR, Temel JS, Temin S, Smith TJ PMID: 28972832 [PubMed – indexed for MEDLINE]
Origen: Integration of Palliative Care Into Standard Oncology Care: ASCO Clinical Practice Guideline Update Summary. – PubMed

Related Articles Palliative and end of life care of people with diabetes: Issues, challenges and strategies. Diabetes Res Clin Pract. 2018 Sep;143:454-463 Authors: Dunning T, Martin P Abstract Palliative and end of life care are essential, but largely overlooked, aspects of comprehensive, personalised diabetes care. Life expectancy is lower in people with diabetes than in the general population due to complications and comorbidities, especially those associated with obesity such as cardiovascular disease, frailty and cancer. This paper makes the case for early initiation of palliative care and proactive planning for end of life. Early use of palliative care improves symptom…
Origen: Palliative and end of life care of people with diabetes: Issues, challenges and strategies. – PubMed

Related Articles Managing people with diabetes during the cancer palliation in the era of simultaneous care. Diabetes Res Clin Pract. 2018 Sep;143:443-453 Authors: Ferrari P, Giardini A, Negri EM, Villani G, Preti P, AMD Diabetes and Cancer working group Abstract Managing people with diabetes and cancer during palliation constitutes a daunting challenge. Cancer, diabetes and treatment toxicity could be seen as a «Bermuda Triangle» for physician and health care professionals in general. Based on literature review, the present paper stresses the distinctive aspects that diabetes and cancer together involve and bring out. Considering the simultaneous care approach as the basement…
Origen: Managing people with diabetes during the cancer palliation in the era of simultaneous care. – PubMed

Related Articles Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. Ann Nucl Med. 2018 Oct;32(8):553-560 Authors: Seider MJ, Pugh SL, Langer C, Wyatt G, Demas W, Rashtian A, Clausen CL, Derdel JD, Cleary SF, Peters CA, Ramalingam A, Clarkson JE, Tomblyn M, Rabinovitch RA, Kachnic LA, Berk LB, NRG Oncology Abstract BACKGROUND: Skeletal-related events (SREs), common sequelae of metastatic cancer, are reduced by bisphosphonates. In this study, it was postulated that radiopharmaceuticals, added to bisphosphonates, could further decrease…
Origen: Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial. – PubMed

Related Articles Supportive Care in Lung Cancer: Improving Value in the Era of Modern Therapies. Am Soc Clin Oncol Educ Book. 2018 May 23;(38):716-725 Authors: Balboni TA, Hui KP, Kamal AH Abstract Driven by a discipline-wide imperative to maximize patient centeredness and value, supportive care services have experienced remarkable growth and acceptance in oncology care. Two such services with a growing evidence base and examples of routine integration into usual oncology care are palliative care and integrative medicine. Both focus on the patient experience with cancer during and after cancer-directed treatments occur, from diagnosis through survivorship or end-of-life care. With…
Origen: Supportive Care in Lung Cancer: Improving Value in the Era of Modern Therapies. – PubMed